Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Laboratory Studies FOR Diagnosing AND Managing Inflammatory Bowel Disease | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Knee Orthosis | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Kidney Transplant | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Ixabepilone Ixempra 0 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Islet Cell Transplantation | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Isatuximab Irfc Sarclisa | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Irinotecan Liposomal Onivyde | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Ipilimumab Yervoy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Intravitreal Implants | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Intravenous Anesthetics FOR OFF Label Indications | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Intraperitoneal Chemotherapy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Nerve Fiber Density Testing | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Intraoperative Neurophysiologic Monitoring Sensory Evoked Potentials Motor Evoked Potentials EEG Monitoring 2 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Intraocular Lens 2 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Intracellular Micronutrient Testing Panel | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Intra Articular Hyaluronan Injections FOR Osteoarthritis OF THE Knee | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Intra Arterial_intravenous Therapeutic Procedures | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Interspinous AND Interlaminar Stabilization_distraction Devices Spacers | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Interim Positron Emission Tomography Scanning IN Oncology TO Detect Early Response During Treatment | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Interferential Stimulator | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Intensity Modulated Radiotherapy Central Nervous System Tumors | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Intensity Modulated Radiotherapy Cancer OF THE Head AND Neck OR | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Intensity Modulated Radiotherapy Abdomen AND Pelvis | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Intensity Modulated Radiotherapy OF THE Prostate | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Intensity Modulated Radiotherapy OF THE Breast AND Lung | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Inotuzumab Ozogamicin Besponsa | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Injectable Collagenase Clostridium Histolyticum | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Inhalation Products FOR THE Management OF Cystic Fibrosis | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Infliximab | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Inebilizumab Cdon Uplizna | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | IN Vitro Allergy Testing | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Implantable Pulmonary Artery Pressure Measurement Device | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Implantable Hormone Replacement Pellets | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Impedance Cardiography IN Hypertension | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Immune Prophylaxis FOR Respiratory Syncytial Virus RSV | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Immune Globulin Therapy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Ilizarov Bone Lengthening | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Idursulfase Elaprase | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Ibalizumab Uiyk Trogarzo | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Hyperbaric Oxygen Therapy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Hydroxyprogesterone Caproate Injection AS A Technique TO Reduce | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Hydrogel Spacer USE During Radiotherapy FOR Prostate Cancer | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Human Growth Hormone | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Hospice | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Homocysteine Testing IN THE Screening Diagnosis AND Management OF Cardiovascular Disease AND Venous Thromboembolic Disease | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Home Uterine Activity Monitor | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Home Pulse Oximetry Device | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Home Health Extended Hours | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Home Dialysis Equipment AND Supplies | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Home Cervical Traction Therapy | New policy |